Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination
JAMA Netw Open. 2021 Oct 1;4(10):e2131034. doi: 10.1001/jamanetworkopen.2021.31034. ABSTRACT IMPORTANCE: Allergic history in individuals with confirmed anaphylaxis to a messenger RNA (mRNA) COVID-19 vaccine is
Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes
Eur J Immunol. 2002 Jan;32(1):67-76. doi: 10.1002/1521-4141(200201)32:13.0.CO;2-3. ABSTRACT Secretory phospholipases A2 (sPLA2) are released in the blood of patients with various inflammatory diseases and exert
Group V secretory phospholipase A2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation
J Immunol. 2013 Jun 15;190(12):5927-38. doi: 10.4049/jimmunol.1203202. Epub 2013 May 6. ABSTRACT We reported that Pla2g5-null mice lacking group V secretory phospholipase A2 (gV-sPLA2) showed
Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells
J Exp Med. 2011 Nov 21;208(12):2511-24. doi: 10.1084/jem.20102545. Epub 2011 Oct 31. ABSTRACT Naive antiviral CD8(+) T cells are activated in the draining LN (DLN)
Maintaining Safety with SARS-CoV-2 Vaccines
N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30. NO ABSTRACT PMID:33378605 | PMC:PMC7787218 | DOI:10.1056/NEJMra2035343
Legends of allergy and immunology: K. Frank Austen
Allergy. 2020 Apr;75(4):1001-1002. doi: 10.1111/all.14066. Epub 2019 Oct 21. NO ABSTRACT PMID:31560800 | DOI:10.1111/all.14066